OTC Markets Hosts Virtual Investor Presentation with Adrian Rawcliffe, CEO of Adaptimmune Therapeutics, and Michael Kim, Senior Analyst at Zacks SCR [Yahoo! Finance]
Adaptimmune Therapeutics plc - American Depositary Shares (ADAP)
Last adaptimmune therapeutics plc - american depositary shares earnings: 5/9 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.adaptimmune.com/phoenix.zhtml?c=253991&p=irol-newsarticle&id=2255800
Company Research
Source: Yahoo! Finance
My name is Anthony Kraus, and on behalf of OTC Markets, as well as our co-host, Zacks Small-Cap Research. We're very pleased you have joined us for our next live presentation from Adaptimmune Therapeutics. This session will be moderated by Michael Kim, senior Analyst at Zacks Small-Cap Research. Please note, you can submit questions for the presenter in the box to the left of the slides. You can also view a company's availability for one-on-one meetings through the Schedule Meetings tab found on the conference platform. At this point, I'm very pleased to welcome Adrian Rawcliffe, Chief Executive Officer of Adaptimmune Therapeutics, which trades on NASDAQ under the symbol ADAP. Welcome, Adrian and Michael. Adrian Rawcliffe: Thank you. Michael Kim: Great. Thanks Anthony, and good afternoon, everyone. Thank you for joining us today. Again, I'm happy to have with us Adrian Rawcliffe, Chief Executive Officer of Adaptimmune, a company that we initiated coverage on earlier this year with
Show less
Read more
Impact Snapshot
Event Time:
ADAP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADAP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADAP alerts
High impacting Adaptimmune Therapeutics plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
ADAP
News
- Adaptimmune to Participate in Scientific and Medical Conferences this November and December [Yahoo! Finance]Yahoo! Finance
- Immuno-Oncology 360º Announces 2025 Keynotes and Featured Speakers for the 11th Annual Meeting in BostonPR Web
- ReCode Announces Two Key Additions to Scientific Advisory BoardBusiness Wire
- Adaptimmune Therapeutics plc's (NASDAQ:ADAP) top owners are individual investors with 39% stake, while 28% is held by institutions [Yahoo! Finance]Yahoo! Finance
- Unlock the Full Potential of Cell and Gene Therapies: The 2024 GenScript Biotech Global Forum Heads to LondonPR Newswire
ADAP
Analyst Actions
- 8/13/24 - HC Wainwright
ADAP
Sec Filings
- 11/1/24 - Form 8-K
- 9/23/24 - Form 8-K
- 8/12/24 - Form 10-Q
- ADAP's page on the SEC website